BIOCRYST PHARMACEUTICALS INC — All Filings
1,001 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13E3/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 3RD QTR. 10-Q FOR BIOCRYST PHARM. | 0000891554-96-000855 | Nov 14, 1996 | Sep 30, 1996 |
| 424B4 | BIOCRYST PHARMACEUTICALS, INC. | 0000950112-96-003467 | Sep 26, 1996 | — |
| S-3/A | BIOCRYST PHARMACEUTICALS, INC. | 0000950112-96-003436 | Sep 25, 1996 | — |
| S-3/A | — | 0000950112-96-003418 | Sep 24, 1996 | — |
| 10-K405/A | BIOCRYST PHARMACEUTICALS, INC. | 0000950112-96-003434 | Sep 24, 1996 | Dec 31, 1995 |
| S-3/A | BIOCRYST PHARMACEUTICALS, INC. | 0000950112-96-002991 | Aug 21, 1996 | — |
| 10-Q | — | 0000950112-96-002797 | Aug 13, 1996 | Jun 30, 1996 |
| 8-K/A | BIOCRYST PHARMACEUTICLES, INC. | 0000950112-96-002605 | Aug 2, 1996 | May 30, 1996 |
| S-3 | BIOCRYST PHARMACEUTICALS, INC. | 0000950112-96-002228 | Jun 28, 1996 | — |
| 8-K | — | 0000950112-96-002150 | Jun 25, 1996 | May 3, 1996 |
| SC 13G/A | — | 0000864047-96-000005 | Feb 13, 1996 | — |
| SC 13G | — | 0000864047-95-000114 | Feb 14, 1995 | — |